BridgeBio Pharma

YTD

ALL

Trade BridgeBio Pharma 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BBIO

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development.

CEO

Neil Kumar

CEONeil Kumar

Employees

730

Employees730

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2015

Founded2015

Employees

730

Employees730

BBIO Key Statistics

Market cap

10.49B

Market cap10.49B

Price-Earnings ratio

-13.25

Price-Earnings ratio-13.25

Dividend yield

—

Dividend yield—

Average volume

1.64M

Average volume1.64M

High today

$56.29

High today$56.29

Low today

$54.23

Low today$54.23

Open price

$54.71

Open price$54.71

Volume

1.50M

Volume1.50M

52 Week high

$57.49

52 Week high$57.49

52 Week low

$21.72

52 Week low$21.72

Analyst ratings

90%

of 21 ratings

Buy

90.5%

Hold

4.8%

Sell

4.8%

People also own

Based on the portfolios of people who own BBIO. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…